Trials / Unknown
UnknownNCT05669105
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Sanguine Biosciences · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to collect biospecimen samples (e.g., whole blood) from participants diagnosed with active lung cancer to investigate the immune response to develop treatments and therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Specimen sample | Participants will have up to 100 mL of whole blood collected. |
Timeline
- Start date
- 2022-02-19
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2022-12-30
- Last updated
- 2023-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05669105. Inclusion in this directory is not an endorsement.